Patient Selection for Stroke Endovascular Therapy— DWI-ASPECTS Thresholds Should Vary among Age Groups: Insights from the RECOST Study

References

1. 1.↵
   2. Roger VL,
   3. Go AS,
   4. Lloyd-Jones DM, et al

   . Heart disease and stroke statistics: 2011 update: a report from the American Heart Association. Circulation 2011;123:e18–e209

   FREE Full Text
2. 2.↵
   2. Miniño AM,
   3. Murphy SL,
   4. Xu J, et al

   . Deaths: final data for 2008. Natl Vital Stat Rep 2011;59:1–126

   PubMed
3. 3.↵
   2. Kelly-Hayes M,
   3. Beiser A,
   4. Kase CS, et al

   . The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis 2003;12:119–26

   CrossRefPubMed
4. 4.↵
   2. Truelsen T,
   3. Piechowski-Jozwiak B,
   4. Bonita R, et al

   . Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 2006;13:581–98

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Hacke W,
   3. Kaste M,
   4. Bluhmki E, et al

   . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317–29

   CrossRefPubMedWeb of Science
6. 6.↵
   Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581–87

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Longstreth WT Jr.,
   3. Katz R,
   4. Tirschwell DL, et al

   . Intravenous tissue plasminogen activator and stroke in the elderly. Am J Emerg Med 2010;28:359–63

   CrossRefPubMed
8. 8.↵
   2. Berrouschot J,
   3. Rother J,
   4. Glahn J, et al

   . Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients. Stroke 2005;36:2421–25

   Abstract/FREE Full Text
9. 9.↵
   2. Engelter ST,
   3. Bonati LH,
   4. Lyrer PA

   . Intravenous thrombolysis in stroke patients of > or = 80 versus < 80 years of age: a systematic review across cohort studies. Age Ageing 2006;35:572–80

   Abstract/FREE Full Text
10. 10.↵
    2. Heuschmann PU,
    3. Kolominsky-Rabas PL,
    4. Misselwitz B, et al

    . Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med 2004;164:1761–68

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Wardlaw JM,
    3. Murray V,
    4. Berge E, et al

    . Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 2012;379:2364–72

    CrossRefPubMedWeb of Science
12. 12.↵
    2. García-Caldentey J,
    3. Alonso de Lecinana M,
    4. Simal P, et al

    . Intravenous thrombolytic treatment in the oldest old. Stroke Res Treat 2012;2012:923676

    PubMed
13. 13.↵
    2. Smith WS,
    3. Sung G,
    4. Saver J, et al

    . Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205–12

    Abstract/FREE Full Text
14. 14.↵
    2. Rha JH,
    3. Saver JL

    . The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967–73

    Abstract/FREE Full Text
15. 15.↵
    2. Mazighi M,
    3. Serfaty JM,
    4. Labreuche J, et al

    . Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009;8:802–09

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Roth C,
    3. Papanagiotou P,
    4. Behnke S, et al

    . Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 2010;41:2559–67

    Abstract/FREE Full Text
17. 17.↵
    Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761–68

    Abstract/FREE Full Text
18. 18.↵
    2. Saver JL,
    3. Jahan R,
    4. Levy EI, et al

    . Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241–49

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Castaño C,
    3. Dorado L,
    4. Guerrero C, et al

    . Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010;41:1836–40

    Abstract/FREE Full Text
20. 20.↵
    2. Costalat V,
    3. Machi P,
    4. Lobotesis K, et al

    . Rescue, combined, and stand-alone thrombectomy in the management of large vessel occlusion stroke using the Solitaire device: a prospective 50-patient single-center study: timing, safety, and efficacy. Stroke 2011;42:1929–35

    Abstract/FREE Full Text
21. 21.↵
    2. Machi P,
    3. Costalat V,
    4. Lobotesis K, et al

    . Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients. J Neurointerv Surg 2012;4:62–66

    Abstract/FREE Full Text
22. 22.↵
    2. Pexman JH,
    3. Barber PA,
    4. Hill MD, et al

    . Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 2001;22:1534–42

    Abstract/FREE Full Text
23. 23.↵
    2. Barber PA,
    3. Demchuk AM,
    4. Zhang J, et al

    . Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy: ASPECTS Study Group—Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670–74

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Butcher KS,
    3. Parsons M,
    4. MacGregor L, et al

    . Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005;36:1153–59

    Abstract/FREE Full Text
25. 25.↵
    2. Wittsack HJ,
    3. Ritzl A,
    4. Fink GR, et al

    . MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. Radiology 2002;222:397–403

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Hacke W,
    3. Kaste M,
    4. Fieschi C, et al

    . Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–25

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Hacke W,
    3. Kaste M,
    4. Fieschi C, et al

    . Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245–51

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Furlan A,
    3. Higashida R,
    4. Wechsler L, et al

    . Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study—a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

    CrossRefPubMedWeb of Science
29. 29.↵
    IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II study. Stroke 2007;38:2127–35

    Abstract/FREE Full Text
30. 30.↵
    2. Rankin J

    . Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 1957;2:200–15

    FREE Full Text
31. 31.↵
    2. van Swieten JC,
    3. Koudstaal PJ,
    4. Visser MC, et al

    . Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–07

    Abstract/FREE Full Text
32. 32.↵
    2. Saqqur M,
    3. Uchino K,
    4. Demchuk AM, et al

    . Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948–54

    Abstract/FREE Full Text
33. 33.↵
    2. Linfante I,
    3. Llinas RH,
    4. Selim M, et al

    . Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 2002;33:2066–71

    Abstract/FREE Full Text
34. 34.↵
    2. Molina CA,
    3. Alexandrov AV,
    4. Demchuk AM, et al

    . Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 2004;35:151–56

    Abstract/FREE Full Text
35. 35.↵
    2. Pereira VM,
    3. Gralla J,
    4. Davalos A, et al

    . Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire flow restoration in acute ischemic stroke. Stroke 2013;44:2802–07

    Abstract/FREE Full Text
36. 36.↵
    2. Loh Y,
    3. Kim D,
    4. Shi ZS, et al

    . Higher rates of mortality but not morbidity follow intracranial mechanical thrombectomy in the elderly. AJNR Am J Neuroradiol 2010;31:1181–85

    Abstract/FREE Full Text
37. 37.↵
    2. Adams HP Jr.,
    3. Davis PH,
    4. Leira EC, et al

    . Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53:126–31

    CrossRef
38. 38.↵
    2. Costalat V,
    3. Lobotesis K,
    4. Machi P, et al

    . Prognostic factors related to clinical outcome following thrombectomy in ischemic stroke (RECOST study): 50 patients prospective study. Eur J Radiol 2012;81:4075–82

    CrossRefPubMed
39. 39.↵
    2. Dávalos A,
    3. Pereira VM,
    4. Chapot R, et al

    . Retrospective multicenter study of Solitaire FR for revascularization in the treatment of acute ischemic stroke. Stroke 2012;43:2699–705

    Abstract/FREE Full Text
40. 40.↵
    2. Epstein SE,
    3. Lassance-Soares RM,
    4. Faber JE, et al

    . Effects of aging on the collateral circulation, and therapeutic implications. Circulation 2012;125:3211–19

    FREE Full Text
41. 41.↵
    2. Hecht N,
    3. He J,
    4. Kremenetskaia I, et al

    . Cerebral hemodynamic reserve and vascular remodeling in C57/BL6 mice are influenced by age. Stroke 2012;43:3052–62

    Abstract/FREE Full Text
42. 42.↵
    2. Di Carlo A,
    3. Lamassa M,
    4. Pracucci G, et al

    . Stroke in the very old: clinical presentation and determinants of 3-month functional outcome: a European perspective—European BIOMED Study of Stroke Care Group. Stroke 1999;30:2313–19

    Abstract/FREE Full Text
43. 43.↵
    2. Denti L,
    3. Scoditti U,
    4. Tonelli C, et al

    . The poor outcome of ischemic stroke in very old people: a cohort study of its determinants. J Am Geriatr Soc 2010;58:12–17

    CrossRefPubMed
44. 44.↵
    2. Yoo AJ,
    3. Chaudhry ZA,
    4. Nogueira RG, et al

    . Infarct volume is a pivotal biomarker after intra-arterial stroke therapy. Stroke 2012;43:1323–30

    Abstract/FREE Full Text
45. 45.↵
    2. Yoo AJ,
    3. Verduzco LA,
    4. Schaefer PW, et al

    . MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009;40:2046–54

    Abstract/FREE Full Text
46. 46.↵
    2. Sanák D,
    3. Nosal V,
    4. Horak D, et al

    . Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis. Neuroradiology 2006;48:632–39

    CrossRefPubMedWeb of Science
47. 47.↵
    2. Nezu T,
    3. Koga M,
    4. Kimura K, et al

    . Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry. Neurology 2010;75:555–61

    CrossRef
48. 48.↵
    2. de Margerie-Mellon C,
    3. Turc G,
    4. Tisserand M, et al

    . Can DWI-ASPECTS substitute for lesion volume in acute stroke? Stroke 2013;44:3565–67

    Abstract/FREE Full Text